nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—MAP2—Docetaxel—head and neck cancer	0.775	0.912	CbGbCtD
Estramustine—ABCB1—Vinblastine—head and neck cancer	0.0255	0.0301	CbGbCtD
Estramustine—ABCB1—Docetaxel—head and neck cancer	0.021	0.0248	CbGbCtD
Estramustine—CYP3A4—Vinblastine—head and neck cancer	0.0153	0.018	CbGbCtD
Estramustine—CYP3A4—Docetaxel—head and neck cancer	0.0126	0.0148	CbGbCtD
Estramustine—Myelosuppression—Vinblastine—head and neck cancer	0.00431	0.0523	CcSEcCtD
Estramustine—Myelosuppression—Hydroxyurea—head and neck cancer	0.00393	0.0477	CcSEcCtD
Estramustine—Developmental delay—Fluorouracil—head and neck cancer	0.00349	0.0423	CcSEcCtD
Estramustine—Congenital anomaly—Fluorouracil—head and neck cancer	0.00349	0.0423	CcSEcCtD
Estramustine—MAP1A—saliva-secreting gland—head and neck cancer	0.00321	0.0985	CbGeAlD
Estramustine—Myelosuppression—Fluorouracil—head and neck cancer	0.00283	0.0343	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00265	0.0769	CbGpPWpGaD
Estramustine—MAP1A—trachea—head and neck cancer	0.00248	0.076	CbGeAlD
Estramustine—MAP2—neck—head and neck cancer	0.00234	0.0717	CbGeAlD
Estramustine—Lacrimation—Fluorouracil—head and neck cancer	0.00225	0.0274	CcSEcCtD
Estramustine—Tenderness—Hydroxyurea—head and neck cancer	0.00211	0.0256	CcSEcCtD
Estramustine—Raised liver function tests—Docetaxel—head and neck cancer	0.00207	0.0252	CcSEcCtD
Estramustine—Myelosuppression—Docetaxel—head and neck cancer	0.00204	0.0248	CcSEcCtD
Estramustine—MAP1A—thyroid gland—head and neck cancer	0.00196	0.0601	CbGeAlD
Estramustine—MAP2—parotid gland—head and neck cancer	0.00191	0.0584	CbGeAlD
Estramustine—MAP2—saliva-secreting gland—head and neck cancer	0.00183	0.056	CbGeAlD
Estramustine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00176	0.0213	CcSEcCtD
Estramustine—MAP1A—head—head and neck cancer	0.00174	0.0533	CbGeAlD
Estramustine—Lacrimation—Docetaxel—head and neck cancer	0.00163	0.0198	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—RARB—head and neck cancer	0.00161	0.0467	CbGpPWpGaD
Estramustine—Tenderness—Fluorouracil—head and neck cancer	0.00152	0.0184	CcSEcCtD
Estramustine—ESR2—neck—head and neck cancer	0.00152	0.0465	CbGeAlD
Estramustine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0015	0.0182	CcSEcCtD
Estramustine—Embolism—Docetaxel—head and neck cancer	0.00149	0.0181	CcSEcCtD
Estramustine—Lacrimation increased—Fluorouracil—head and neck cancer	0.00144	0.0175	CcSEcCtD
Estramustine—MAP2—trachea—head and neck cancer	0.00141	0.0432	CbGeAlD
Estramustine—ESR2—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00127	0.0369	CbGpPWpGaD
Estramustine—MAP1A—lymph node—head and neck cancer	0.00122	0.0373	CbGeAlD
Estramustine—Pancytopenia—Vinblastine—head and neck cancer	0.0012	0.0146	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—MAPK3—head and neck cancer	0.00117	0.0341	CbGpPWpGaD
Estramustine—Depression—Vinblastine—head and neck cancer	0.00113	0.0137	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—MAPK1—head and neck cancer	0.00112	0.0324	CbGpPWpGaD
Estramustine—MAP2—thyroid gland—head and neck cancer	0.00111	0.0341	CbGeAlD
Estramustine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00111	0.0135	CcSEcCtD
Estramustine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00111	0.0135	CcSEcCtD
Estramustine—Myocardial infarction—Vinblastine—head and neck cancer	0.00111	0.0134	CcSEcCtD
Estramustine—Pancytopenia—Hydroxyurea—head and neck cancer	0.0011	0.0133	CcSEcCtD
Estramustine—ESR2—connective tissue—head and neck cancer	0.00109	0.0333	CbGeAlD
Estramustine—ESR1—neck—head and neck cancer	0.00104	0.0318	CbGeAlD
Estramustine—Lacrimation increased—Docetaxel—head and neck cancer	0.00104	0.0126	CcSEcCtD
Estramustine—ESR2—epithelium—head and neck cancer	0.00103	0.0316	CbGeAlD
Estramustine—MAP2—head—head and neck cancer	0.000988	0.0303	CbGeAlD
Estramustine—Lethargy—Fluorouracil—head and neck cancer	0.000982	0.0119	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000979	0.0284	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000962	0.0117	CcSEcCtD
Estramustine—Cardiac arrest—Fluorouracil—head and neck cancer	0.000915	0.0111	CcSEcCtD
Estramustine—Skin exfoliation—Docetaxel—head and neck cancer	0.000913	0.0111	CcSEcCtD
Estramustine—MAP2—MAPK Cascade—HRAS—head and neck cancer	0.000897	0.026	CbGpPWpGaD
Estramustine—Alopecia—Vinblastine—head and neck cancer	0.000896	0.0109	CcSEcCtD
Estramustine—Dry skin—Fluorouracil—head and neck cancer	0.000882	0.0107	CcSEcCtD
Estramustine—Alopecia—Hydroxyurea—head and neck cancer	0.000817	0.00992	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—RARB—head and neck cancer	0.000811	0.0235	CbGpPWpGaD
Estramustine—Thrombophlebitis—Docetaxel—head and neck cancer	0.000802	0.00974	CcSEcCtD
Estramustine—ESR2—lymphoid tissue—head and neck cancer	0.000795	0.0244	CbGeAlD
Estramustine—Leukopenia—Vinblastine—head and neck cancer	0.00079	0.00959	CcSEcCtD
Estramustine—Pancytopenia—Fluorouracil—head and neck cancer	0.00079	0.00959	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—XRCC1—head and neck cancer	0.000784	0.0228	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000766	0.0093	CcSEcCtD
Estramustine—ESR1—connective tissue—head and neck cancer	0.000744	0.0228	CbGeAlD
Estramustine—Hot flush—Docetaxel—head and neck cancer	0.000742	0.00901	CcSEcCtD
Estramustine—Menopausal symptoms—Docetaxel—head and neck cancer	0.000736	0.00893	CcSEcCtD
Estramustine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000731	0.00887	CcSEcCtD
Estramustine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000727	0.00882	CcSEcCtD
Estramustine—ESR1—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.000722	0.021	CbGpPWpGaD
Estramustine—ESR2—thyroid gland—head and neck cancer	0.000722	0.0221	CbGeAlD
Estramustine—Leukopenia—Hydroxyurea—head and neck cancer	0.00072	0.00875	CcSEcCtD
Estramustine—Lethargy—Docetaxel—head and neck cancer	0.000708	0.0086	CcSEcCtD
Estramustine—ESR1—epithelium—head and neck cancer	0.000707	0.0217	CbGeAlD
Estramustine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000705	0.00856	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—TGFA—head and neck cancer	0.000696	0.0202	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000694	0.00843	CcSEcCtD
Estramustine—MAP2—lymph node—head and neck cancer	0.000692	0.0212	CbGeAlD
Estramustine—Anorexia—Vinblastine—head and neck cancer	0.000687	0.00834	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—TP53—head and neck cancer	0.000684	0.0199	CbGpPWpGaD
Estramustine—Oedema—Hydroxyurea—head and neck cancer	0.000657	0.00798	CcSEcCtD
Estramustine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000643	0.00781	CcSEcCtD
Estramustine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000641	0.00778	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.000641	0.0186	CbGpPWpGaD
Estramustine—ESR2—head—head and neck cancer	0.00064	0.0196	CbGeAlD
Estramustine—Dry skin—Docetaxel—head and neck cancer	0.000636	0.00773	CcSEcCtD
Estramustine—Anorexia—Hydroxyurea—head and neck cancer	0.000626	0.0076	CcSEcCtD
Estramustine—Decreased appetite—Vinblastine—head and neck cancer	0.000626	0.0076	CcSEcCtD
Estramustine—Alopecia—Fluorouracil—head and neck cancer	0.000588	0.00714	CcSEcCtD
Estramustine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000586	0.00711	CcSEcCtD
Estramustine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000571	0.00693	CcSEcCtD
Estramustine—Pancytopenia—Docetaxel—head and neck cancer	0.00057	0.00692	CcSEcCtD
Estramustine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000552	0.016	CbGpPWpGaD
Estramustine—ESR1—lymphoid tissue—head and neck cancer	0.000544	0.0167	CbGeAlD
Estramustine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000527	0.0064	CcSEcCtD
Estramustine—Myocardial infarction—Docetaxel—head and neck cancer	0.000524	0.00637	CcSEcCtD
Estramustine—Leukopenia—Fluorouracil—head and neck cancer	0.000519	0.0063	CcSEcCtD
Estramustine—ESR1—thyroid gland—head and neck cancer	0.000494	0.0152	CbGeAlD
Estramustine—Chest pain—Fluorouracil—head and neck cancer	0.000493	0.00599	CcSEcCtD
Estramustine—Diarrhoea—Vinblastine—head and neck cancer	0.000493	0.00598	CcSEcCtD
Estramustine—Estrone—CYP1A1—head and neck cancer	0.000486	0.423	CrCbGaD
Estramustine—Oedema—Fluorouracil—head and neck cancer	0.000473	0.00574	CcSEcCtD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000469	0.0136	CbGpPWpGaD
Estramustine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000463	0.00562	CcSEcCtD
Estramustine—Vomiting—Vinblastine—head and neck cancer	0.000458	0.00556	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000454	0.0132	CbGpPWpGaD
Estramustine—Headache—Vinblastine—head and neck cancer	0.000451	0.00548	CcSEcCtD
Estramustine—Anorexia—Fluorouracil—head and neck cancer	0.000451	0.00547	CcSEcCtD
Estramustine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000449	0.00546	CcSEcCtD
Estramustine—ESR2—lymph node—head and neck cancer	0.000448	0.0137	CbGeAlD
Estramustine—Flushing—Docetaxel—head and neck cancer	0.000446	0.00541	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000442	0.0128	CbGpPWpGaD
Estramustine—ESR1—head—head and neck cancer	0.000439	0.0134	CbGeAlD
Estramustine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000428	0.0124	CbGpPWpGaD
Estramustine—Nausea—Vinblastine—head and neck cancer	0.000428	0.00519	CcSEcCtD
Estramustine—Insomnia—Fluorouracil—head and neck cancer	0.000428	0.00519	CcSEcCtD
Estramustine—Alopecia—Docetaxel—head and neck cancer	0.000424	0.00515	CcSEcCtD
Estramustine—Dyspnoea—Fluorouracil—head and neck cancer	0.000422	0.00512	CcSEcCtD
Estramustine—Vomiting—Hydroxyurea—head and neck cancer	0.000418	0.00507	CcSEcCtD
Estramustine—Rash—Hydroxyurea—head and neck cancer	0.000414	0.00503	CcSEcCtD
Estramustine—Dermatitis—Hydroxyurea—head and neck cancer	0.000414	0.00502	CcSEcCtD
Estramustine—Headache—Hydroxyurea—head and neck cancer	0.000411	0.005	CcSEcCtD
Estramustine—Decreased appetite—Fluorouracil—head and neck cancer	0.000411	0.00499	CcSEcCtD
Estramustine—Muscle spasms—Docetaxel—head and neck cancer	0.000402	0.00488	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000402	0.0117	CbGpPWpGaD
Estramustine—Nausea—Hydroxyurea—head and neck cancer	0.00039	0.00474	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.000388	0.0113	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.000388	0.0113	CbGpPWpGaD
Estramustine—Leukopenia—Docetaxel—head and neck cancer	0.000374	0.00454	CcSEcCtD
Estramustine—Estradiol—CYP1A1—head and neck cancer	0.000368	0.32	CrCbGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000356	0.0103	CbGpPWpGaD
Estramustine—Chest pain—Docetaxel—head and neck cancer	0.000356	0.00432	CcSEcCtD
Estramustine—Oedema—Docetaxel—head and neck cancer	0.000341	0.00414	CcSEcCtD
Estramustine—Pruritus—Fluorouracil—head and neck cancer	0.000334	0.00406	CcSEcCtD
Estramustine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000334	0.00406	CcSEcCtD
Estramustine—Anorexia—Docetaxel—head and neck cancer	0.000325	0.00395	CcSEcCtD
Estramustine—Diarrhoea—Fluorouracil—head and neck cancer	0.000323	0.00393	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000323	0.00937	CbGpPWpGaD
Estramustine—Insomnia—Docetaxel—head and neck cancer	0.000309	0.00375	CcSEcCtD
Estramustine—ESR1—lymph node—head and neck cancer	0.000307	0.00941	CbGeAlD
Estramustine—Dyspnoea—Docetaxel—head and neck cancer	0.000304	0.00369	CcSEcCtD
Estramustine—Vomiting—Fluorouracil—head and neck cancer	0.000301	0.00365	CcSEcCtD
Estramustine—Rash—Fluorouracil—head and neck cancer	0.000298	0.00362	CcSEcCtD
Estramustine—Dermatitis—Fluorouracil—head and neck cancer	0.000298	0.00362	CcSEcCtD
Estramustine—Decreased appetite—Docetaxel—head and neck cancer	0.000297	0.0036	CcSEcCtD
Estramustine—Headache—Fluorouracil—head and neck cancer	0.000296	0.0036	CcSEcCtD
Estramustine—Testosterone—CYP1A1—head and neck cancer	0.000295	0.257	CrCbGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000291	0.00846	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000289	0.00838	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.000283	0.00822	CbGpPWpGaD
Estramustine—Nausea—Fluorouracil—head and neck cancer	0.000281	0.00341	CcSEcCtD
Estramustine—ABCB1—epithelium—head and neck cancer	0.000279	0.00856	CbGeAlD
Estramustine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00027	0.00784	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.000264	0.00765	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000262	0.00761	CbGpPWpGaD
Estramustine—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.000261	0.00759	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00026	0.00756	CbGpPWpGaD
Estramustine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000259	0.00753	CbGpPWpGaD
Estramustine—ABCB1—trachea—head and neck cancer	0.000247	0.00757	CbGeAlD
Estramustine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000246	0.00714	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.000245	0.0071	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.000243	0.00706	CbGpPWpGaD
Estramustine—Pruritus—Docetaxel—head and neck cancer	0.000241	0.00293	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000241	0.007	CbGpPWpGaD
Estramustine—Diarrhoea—Docetaxel—head and neck cancer	0.000233	0.00284	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000231	0.00672	CbGpPWpGaD
Estramustine—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.000227	0.00658	CbGpPWpGaD
Estramustine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000226	0.00656	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000223	0.00646	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—RARB—head and neck cancer	0.000219	0.00637	CbGpPWpGaD
Estramustine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000217	0.00631	CbGpPWpGaD
Estramustine—Vomiting—Docetaxel—head and neck cancer	0.000217	0.00263	CcSEcCtD
Estramustine—Rash—Docetaxel—head and neck cancer	0.000215	0.00261	CcSEcCtD
Estramustine—ABCB1—lymphoid tissue—head and neck cancer	0.000215	0.00659	CbGeAlD
Estramustine—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.000215	0.00624	CbGpPWpGaD
Estramustine—Dermatitis—Docetaxel—head and neck cancer	0.000215	0.00261	CcSEcCtD
Estramustine—Headache—Docetaxel—head and neck cancer	0.000214	0.0026	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000212	0.00615	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.000206	0.00597	CbGpPWpGaD
Estramustine—Nausea—Docetaxel—head and neck cancer	0.000203	0.00246	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000203	0.00588	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—YAP1—head and neck cancer	0.0002	0.00579	CbGpPWpGaD
Estramustine—ABCB1—thyroid gland—head and neck cancer	0.000195	0.00599	CbGeAlD
Estramustine—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.000185	0.00538	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.000183	0.0053	CbGpPWpGaD
Estramustine—ABCB1—head—head and neck cancer	0.000173	0.00531	CbGeAlD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000167	0.00484	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000165	0.00479	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000157	0.00455	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.000157	0.00455	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00015	0.00436	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00015	0.00436	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000147	0.00426	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.000144	0.00417	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.000143	0.00415	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000142	0.00411	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00014	0.00407	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00014	0.00406	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000137	0.00397	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000134	0.0039	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.000133	0.00386	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000132	0.00384	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000132	0.00383	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.000129	0.00376	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000129	0.00375	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000125	0.00361	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000123	0.00357	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000122	0.00353	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000122	0.00353	CbGpPWpGaD
Estramustine—ABCB1—lymph node—head and neck cancer	0.000121	0.00372	CbGeAlD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000121	0.0035	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000118	0.00342	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000117	0.0034	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000117	0.00339	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000116	0.00337	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.000115	0.00335	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000112	0.00324	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.000111	0.00321	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00011	0.00319	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.00011	0.00319	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000107	0.00311	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000107	0.0031	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000106	0.00307	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RARB—head and neck cancer	0.000106	0.00307	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000102	0.00295	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000101	0.00292	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.0001	0.00291	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.0001	0.00291	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	9.92e-05	0.00288	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—YAP1—head and neck cancer	9.61e-05	0.00279	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	9.54e-05	0.00277	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	9.53e-05	0.00277	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.39e-05	0.00272	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.26e-05	0.00269	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	9.01e-05	0.00261	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NOTCH1—head and neck cancer	9e-05	0.00261	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	8.92e-05	0.00259	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	8.63e-05	0.00251	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	8.62e-05	0.0025	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	8.51e-05	0.00247	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.32e-05	0.00241	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	8.27e-05	0.0024	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	8.15e-05	0.00237	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	8e-05	0.00232	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	7.79e-05	0.00226	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.61e-05	0.00221	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	7.39e-05	0.00215	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	7.2e-05	0.00209	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.14e-05	0.00207	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	7.14e-05	0.00207	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	7.1e-05	0.00206	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.78e-05	0.00197	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	6.77e-05	0.00196	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	6.76e-05	0.00196	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2—head and neck cancer	6.74e-05	0.00196	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	6.61e-05	0.00192	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.47e-05	0.00188	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	6.45e-05	0.00187	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	6.44e-05	0.00187	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.13e-05	0.00178	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	6.07e-05	0.00176	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.91e-05	0.00172	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	5.8e-05	0.00168	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	5.8e-05	0.00168	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	5.77e-05	0.00167	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—UROD—head and neck cancer	5.77e-05	0.00167	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	5.77e-05	0.00167	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	5.73e-05	0.00166	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.34e-05	0.00155	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RARB—head and neck cancer	5.33e-05	0.00155	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.05e-05	0.00147	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	5.01e-05	0.00145	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	4.87e-05	0.00141	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—YAP1—head and neck cancer	4.85e-05	0.00141	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.81e-05	0.0014	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.81e-05	0.0014	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	4.63e-05	0.00134	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	4.54e-05	0.00132	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KISS1—head and neck cancer	4.45e-05	0.00129	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.4e-05	0.00128	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH1—head and neck cancer	4.33e-05	0.00126	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.26e-05	0.00124	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.22e-05	0.00122	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.21e-05	0.00122	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.17e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	4.11e-05	0.00119	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	4.09e-05	0.00119	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.04e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.04e-05	0.00117	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.99e-05	0.00116	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.78e-05	0.0011	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GRP—head and neck cancer	3.67e-05	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.59e-05	0.00104	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT6—head and neck cancer	3.56e-05	0.00103	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—UROD—head and neck cancer	3.56e-05	0.00103	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.41e-05	0.000989	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.24e-05	0.000941	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—YAP1—head and neck cancer	3.15e-05	0.000914	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.13e-05	0.000908	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.83e-05	0.00082	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.67e-05	0.000776	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.54e-05	0.000738	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.54e-05	0.000738	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MAPK3—head and neck cancer	2.4e-05	0.000696	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NAT2—head and neck cancer	2.4e-05	0.000695	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.21e-05	0.000641	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH1—head and neck cancer	2.18e-05	0.000634	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.14e-05	0.00062	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—DPYD—head and neck cancer	2.1e-05	0.00061	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—YAP1—head and neck cancer	1.99e-05	0.000579	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.8e-05	0.000523	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—head and neck cancer	1.62e-05	0.000469	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.48e-05	0.000428	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	1.42e-05	0.000412	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.29e-05	0.000376	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.23e-05	0.000357	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MAPK3—head and neck cancer	1.21e-05	0.000351	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMS—head and neck cancer	1.2e-05	0.000347	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTM1—head and neck cancer	1.18e-05	0.000343	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX1—head and neck cancer	1.13e-05	0.000329	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.12e-05	0.000326	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—head and neck cancer	9.77e-06	0.000284	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—head and neck cancer	9.53e-06	0.000276	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—head and neck cancer	9.2e-06	0.000267	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—head and neck cancer	8.31e-06	0.000241	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—head and neck cancer	8.22e-06	0.000239	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—head and neck cancer	8.15e-06	0.000237	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK3—head and neck cancer	7.86e-06	0.000228	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK1—head and neck cancer	7.48e-06	0.000217	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—head and neck cancer	7.48e-06	0.000217	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMS—head and neck cancer	7.38e-06	0.000214	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.29e-06	0.000212	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX1—head and neck cancer	6.98e-06	0.000203	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.91e-06	0.000201	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—head and neck cancer	6.67e-06	0.000194	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	6.49e-06	0.000188	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—head and neck cancer	6.28e-06	0.000182	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—head and neck cancer	6e-06	0.000174	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—head and neck cancer	5.82e-06	0.000169	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—head and neck cancer	5.3e-06	0.000154	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.11e-06	0.000119	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.11e-06	0.000119	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.59e-06	0.000104	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—head and neck cancer	3.35e-06	9.73e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.53e-06	7.34e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.07e-06	6e-05	CbGpPWpGaD
